Skip to content

Kyverna Therapeutics, Inc. KYTX Return on invested capital

Return on invested capital at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
13%+4.2pp
Gilead Sciences logo
Gilead SciencesGILD
23.7%+4.4pp
Climb Bio, Inc. logo
Climb Bio, Inc.CLYM
-39.4%-15.9pp
Artiva Biotherapeutics, Inc. logo
Artiva Biotherapeutics, Inc.ARTV
-80.5%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
-59.5%-2.6pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-76.5%+14.9pp

Other financials

Income statement

See full
Operating income-$41.4M+12.7%
Net income-$39.7M+11.0%
EPS (diluted)-$0.66+35.9%

Balance sheet

See full
Cash & equivalents$32.2M-43.4%
Total debt$9.2M+32.1%
Total equity$195.6M-12.7%
Total assets$257.0M-1.4%

Cash flow

See full
Operating cash flow-$41.6M+7.4%
CapEx$2.0K-98.0%
Free cash flow-$33.5M+10.8%

Valuation

See full
Market cap$498.52M+276%
Enterprise value$475.49M+475%

Returns & leverage

See full
Return on equity-74.5%+74.4pp
Debt / equity0.0×
Current ratio8.1×+0.7×

Where this comes from

Calculated from Kyverna Therapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kyverna Therapeutics, Inc.'s return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kyverna Therapeutics, Inc.'s return on invested capital?
Kyverna Therapeutics, Inc. (KYTX) reported return on invested capital of -94.5% in Q1 2026.
How has Kyverna Therapeutics, Inc.'s return on invested capital changed year-over-year?
Kyverna Therapeutics, Inc.'s return on invested capital increased by 5.1% year-over-year, from -99.6% to -94.5%.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.